Relationship of intracerebral pituitary grafts to central neuropeptide systems

The American Journal of Anatomy
K M Knigge

Abstract

Variable amounts of pituitary tissue from neonatal or 30-day-old donor rats were implanted in the recessus triangularis or third ventricle of hypophysectomized male host rats. The pituitary tissue was implanted either immediately or 30 days after hypophysectomy of the host rat. Grafts from donors of either age were capable of maintaining a significant degree of testicular weight in one-third of the implanted animals. Neonatal grafts were not capable of restoring testicular weight when implanted 30 days after hypophysectomy. Final body weights of all graft-bearing animals were greater than those of hypophysectomized controls. The pars distalis of all grafts contained large numbers of cells immunore-active for LH, GH, and ACTH; TSH-immunoreactive cells were sparse. Prolactin-positive cells were extensive in grafts of animals in which the testes were maintained, and virtually absent in grafts of animals with atrophic testes. The fiber systems of three central neuropeptides, LRF, SRIF, and ACTH, were stained and found not to enter the graft. The results suggest that pituitary grafts in the third ventricle may receive their hypophysiotropic neuropeptides from the CSF.

References

Nov 1, 1979·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·L A Sternberger, S A Joseph
Nov 1, 1979·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·S A Joseph, L A Sternberger
Oct 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·K Hofmann, Y Kiso
Dec 1, 1979·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·L A Sternberger
Dec 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·B J BurchanowskiL A Sternberger
May 1, 1967·Endocrinology·H D Purves, N E Sirett
Dec 1, 1968·Endocrinology·H D Purves, N E Sirett
Oct 1, 1969·Endocrinology·N E Sirett, J W Kendall
Apr 1, 1967·Endocrinology·E R Smith, J M Davidson
Apr 28, 1980·Brain Research·C Bennett-ClarkeS A Joseph
Jun 1, 1954·Endocrinology·J W EVERETT
Dec 1, 1958·Endocrinology·M NIKITOVITCH-WINER, J W EVERETT
Jan 1, 1959·Zeitschrift für Zellforschung und mikroskopische Anatomie·A E SANDERS, E G RENNELS
Mar 1, 1961·The American Journal of Physiology·W H FLORSHEIM, K M KNIGGE
Apr 1, 1965·The Journal of Endocrinology·L RUBINSTEIN, K AHREN
Mar 1, 1962·The American Journal of Physiology·K M KNIGGE

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.